Pursuant to the provisions of Regulations 30(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Prism Medico and pharmacy has informed that the Board of Directors in their meeting held on Wednesday, 30th May at 4:00 pm and concluded at 5.00 pm; Considered and Approved and taken on records the standalone and consolidated Audited Financial Results along with Audit Report for the quarter and Financial Year ended on March 31, 2018 as recommended by the Audit Committee; Considered and approved the date of Annual General Meeting and the same shall to be held on 12th July, 2018; Considered and approved the name change of the Company from Prism Medico and Pharmacy to Prism Industries subject to the approval of the Registrar of Companies, Punjab & Chandigarh and the approval of the members.
The above information is a part of company’s filings submitted to BSE.
